A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and supportive therapy in young people at ultra high risk of psychotic disorder: 12 month outcome data

被引：0
|
作者：
Yung, A. R. [1 ,2 ]
Nelson, B. [2 ]
Phillips, L. [3 ]
Francey, S. [2 ]
Leicester, S. [2 ]
Yuen, H. P. [1 ,2 ]
Simmons, M. [1 ,2 ]
Berger, G. [2 ]
Amminger, P. [1 ,2 ]
McGorry, P. D. [1 ,2 ]
机构：
[1] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia
[2] ORYGEN Res Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2008年 / 2卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [21] Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial
    Peters, Katherine B.
    Affronti, Mary L.
    Woodring, Sarah
    Lipp, Eric
    Healy, Patrick
    Herndon, James E.
    Miller, Elizabeth S.
    Freeman, Maria W.
    Randazzo, Dina M.
    Desjardins, Annick
    Friedman, Henry S.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 3463 - 3471
  • [22] Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial
    Katherine B. Peters
    Mary L. Affronti
    Sarah Woodring
    Eric Lipp
    Patrick Healy
    James E. Herndon
    Elizabeth S. Miller
    Maria W. Freeman
    Dina M. Randazzo
    Annick Desjardins
    Henry S. Friedman
    Supportive Care in Cancer, 2022, 30 : 3463 - 3471
  • [23] Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial
    Grilo, CM
    Masheb, RM
    Salant, SL
    BIOLOGICAL PSYCHIATRY, 2005, 57 (10) : 1193 - 1201
  • [24] Randomized, double-blind, placebo-controlled, trial of high-dose intravenous anti-oxidant therapy in severe acute pancreatitis
    Sinwardena, Ajith K.
    Mason, James M.
    Balachandra, Srinivasan
    Bagul, Anil
    Galloway, Simon
    Formela, Laura
    Hardman, Jonathon
    Jamdar, Saurabh
    Schofield, David
    Kay, Pauline
    Virlos, Ioannis T.
    GASTROENTEROLOGY, 2006, 130 (04) : A83 - A83
  • [25] Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study
    English, KM
    Steeds, RP
    Jones, TH
    Diver, MJ
    Channer, KS
    CIRCULATION, 2000, 102 (16) : 1906 - 1911
  • [26] A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy
    Woodle, E. Steve
    First, M. Roy
    Pirsch, John
    Shihab, Fuad
    Gaber, A. Osama
    Van Veldhuisen, Paul
    ANNALS OF SURGERY, 2008, 248 (04) : 564 - 577
  • [27] Pollen low dose intradermal therapy evaluation (PollenLITE): a double-blind randomised placebo-controlled trial of low-dose intradermal grass pollen immunotherapy in seasonal allergic rhinitis
    Slovick, A.
    Douiri, A.
    Muir, R.
    Guerra, A.
    Tsioulos, K.
    Hay, E.
    Emily, L.
    Kelly, J.
    Peacock, J.
    Ying, S.
    Mohamed, S.
    Cousins, D.
    Durham, S.
    Till, S.
    ALLERGY, 2016, 71 : 60 - 60
  • [28] Effect of a low-dose ketamine regimen on pain, mood, cognitive function and memory after major gynaecological surgery: a randomized, double-blind, placebo-controlled trial
    Aubrun, F.
    Gaillat, C.
    Rosenthal, D.
    Dupuis, M.
    Mottet, P.
    Marchetti, F.
    Coriat, P.
    Riou, B.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (02) : 97 - 105
  • [29] Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin
    Rutter, M. K.
    Prais, H. R.
    Charlton-Menys, V.
    Gittins, M.
    Roberts, C.
    Davies, R. R.
    Moorhouse, A.
    Jinadev, P.
    France, M.
    Wiles, P. G.
    Gibson, J. M.
    Dean, J.
    Kalra, P. A.
    Cruickshank, J. K.
    Durrington, P. N.
    DIABETIC MEDICINE, 2011, 28 (01) : 100 - 108
  • [30] Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Nations, Karl R.
    Smits, Jasper A. J.
    Tolin, David F.
    Rothbaum, Barbara O.
    Hofmann, Stefan G.
    Tart, Candyce D.
    Lee, Allen
    Schipper, Jacques
    Sjogren, Magnus
    Xue, Dixi
    Szegedi, Armin
    Otto, Michael W.
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (05) : 647 - 653
12345